Kolls Jay K, Lindén Anders
Division of Pulmonology, Department of Pediatrics, Children's Hospital of Pittsburgh and the University of Pittsburgh, Pittsburgh, PA, USA.
Immunity. 2004 Oct;21(4):467-76. doi: 10.1016/j.immuni.2004.08.018.
IL-17A was cloned more than 10 years ago and six IL-17 family members (IL-17A-F) have subsequently been described. IL-17A is largely produced by activated memory T lymphocytes but stimulates innate immunity and host defense. IL-17A and IL-17F both mobilize neutrophils partly through granulopoeisis and CXC chemokine induction, as well as increased survival locally. IL-17A and IL-17F production by T lymphocytes is regulated by IL-23 independent of T cell receptor activation. Increasing evidence shows that IL-17 family members play an active role in inflammatory diseases, autoimmune diseases, and cancer. This places IL-17 family members and their receptors as potential targets for future pharmacotherapy.
白细胞介素-17A(IL-17A)于十多年前被克隆出来,随后又发现了六个白细胞介素-17家族成员(IL-17A-F)。IL-17A主要由活化的记忆T淋巴细胞产生,但可刺激先天性免疫和宿主防御。IL-17A和IL-17F都部分地通过粒细胞生成和CXC趋化因子诱导以及局部存活率增加来调动中性粒细胞。T淋巴细胞产生IL-17A和IL-17F受白细胞介素-23调节,独立于T细胞受体激活。越来越多的证据表明,IL-17家族成员在炎症性疾病、自身免疫性疾病和癌症中发挥着积极作用。这使得IL-17家族成员及其受体成为未来药物治疗的潜在靶点。